Works matching IS 10870156 AND DT 2013 AND VI 31 AND IP 4


Results: 45
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Medicines from microbiota.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 309, doi. 10.1038/nbt.2548
    By:
    • Olle, Bernat
    Publication type:
    Article
    12
    13

    Trends in microbiome research.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 277, doi. 10.1038/nbt.2546
    By:
    • Jones, Susan
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Spain nudges biotech from nest.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 272, doi. 10.1038/nbt0413-272b
    By:
    • Laursen, Lucas
    Publication type:
    Article
    21

    People.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 364, doi. 10.1038/nbt.2558
    Publication type:
    Article
    22

    The startup bugs.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 279, doi. 10.1038/nbt.2544
    By:
    • Schmidt, Charles
    Publication type:
    Article
    23
    24

    Renewable RNAi.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 319, doi. 10.1038/nbt.2547
    By:
    • Blau, James A;
    • McManus, Michael T
    Publication type:
    Article
    25
    26
    27

    In this issue.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. vii, doi. 10.1038/nbt.2562
    Publication type:
    Article
    28

    Updating benchtop sequencing performance comparison.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 294, doi. 10.1038/nbt.2522
    By:
    • Jünemann, Sebastian;
    • Sedlazeck, Fritz Joachim;
    • Prior, Karola;
    • Albersmeier, Andreas;
    • John, Uwe;
    • Kalinowski, Jörn;
    • Mellmann, Alexander;
    • Goesmann, Alexander;
    • von Haeseler, Arndt;
    • Stoye, Jens;
    • Harmsen, Dag
    Publication type:
    Article
    29

    Research Highlights.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 323, doi. 10.1038/nbt.2557
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37

    Building for big pharma.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 284, doi. 10.1038/nbt.2533
    By:
    • Giniatullina, Asiya;
    • Boorsma, Marco;
    • Mulder, Geert-Jan;
    • van Deventer, Sander
    Publication type:
    Article
    38

    Three deaths sink Affymax.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 270, doi. 10.1038/nbt0413-270a
    By:
    • DeFrancesco, Laura
    Publication type:
    Article
    39
    40

    Monsanto buys microbes.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 270, doi. 10.1038/nbt0413-270b
    By:
    • Waltz, Emily
    Publication type:
    Article
    41

    Translating the human microbiome.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 304, doi. 10.1038/nbt.2543
    By:
    • Brown, James;
    • de Vos, Willem M;
    • DiStefano, Peter S;
    • Doré, Joël;
    • Huttenhower, Curtis;
    • Knight, Rob;
    • Lawley, Trevor D;
    • Raes, Jeroen;
    • Turnbaugh, Peter
    Publication type:
    Article
    42

    FDA dashes Novo's hopes.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 4, p. 266, doi. 10.1038/nbt0413-266
    By:
    • Dorey, Emma
    Publication type:
    Article
    43
    44
    45